Future research will focus on validating the functions of these druggable genes and elucidating the mechanistic pathway of the galangin-ADORA2A interaction, laying a more solid and comprehensive theoretical and practical foundation for PBC treatment. Here, ADORA2A is linked to primary biliary cholangitis.